These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11692239)

  • 1. Rapid MRI using a modified Dixon technique: a non-invasive and effective method for detection and monitoring of fatty metamorphosis of the liver.
    Fishbein MH; Stevens WR
    Pediatr Radiol; 2001 Nov; 31(11):806-9. PubMed ID: 11692239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease.
    Fishbein MH; Mogren C; Gleason T; Stevens WR
    J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):83-8. PubMed ID: 16385259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis.
    Fishbein MH; Miner M; Mogren C; Chalekson J
    J Pediatr Gastroenterol Nutr; 2003 Jan; 36(1):54-61. PubMed ID: 12499997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population.
    Hetterich H; Bayerl C; Peters A; Heier M; Linkohr B; Meisinger C; Auweter S; Kannengießer SA; Kramer H; Ertl-Wagner B; Bamberg F
    Eur Radiol; 2016 Jun; 26(6):1895-904. PubMed ID: 26340812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques.
    Schwenzer NF; Machann J; Martirosian P; Stefan N; Schraml C; Fritsche A; Claussen CD; Schick F
    Invest Radiol; 2008 May; 43(5):330-7. PubMed ID: 18424954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)?
    Chavez-Tapia NC; Tiribelli C
    Gut; 2008 Oct; 57(10):1351-3. PubMed ID: 18791116
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging.
    Radetti G; Kleon W; Stuefer J; Pittschieler K
    Acta Paediatr; 2006 Jul; 95(7):833-7. PubMed ID: 16801180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exercise training and isoflavones on hepatic steatosis in overweight postmenopausal women.
    Barsalani R; Riesco E; Lavoie JM; Dionne IJ
    Climacteric; 2013 Feb; 16(1):88-95. PubMed ID: 22530610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis in Dunnigan-type familial partial lipodystrophy.
    Lüdtke A; Genschel J; Brabant G; Bauditz J; Taupitz M; Koch M; Wermke W; Worman HJ; Schmidt HH
    Am J Gastroenterol; 2005 Oct; 100(10):2218-24. PubMed ID: 16181372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donation.
    Rinella ME; McCarthy R; Thakrar K; Finn JP; Rao SM; Koffron AJ; Abecassis M; Blei AT
    Liver Transpl; 2003 Aug; 9(8):851-6. PubMed ID: 12884199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study assessing differentiation of steatosis hepatis, hepatic iron overload, and combined disease using two-point dixon MRI at 3 T: in vitro and in vivo results of a 2D decomposition technique.
    Boll DT; Marin D; Redmon GM; Zink SI; Merkle EM
    AJR Am J Roentgenol; 2010 Apr; 194(4):964-71. PubMed ID: 20308498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers.
    Ahmed MH
    Scand J Gastroenterol; 2006 Mar; 41(3):372. PubMed ID: 16497631
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging.
    Schuchmann S; Weigel C; Albrecht L; Kirsch M; Lemke A; Lorenz G; Warzok R; Hosten N
    Eur J Radiol; 2007 Jun; 62(3):416-22. PubMed ID: 17267159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients.
    Anty R; Iannelli A; Patouraux S; Bonnafous S; Lavallard VJ; Senni-Buratti M; Amor IB; Staccini-Myx A; Saint-Paul MC; Berthier F; Huet PM; Le Marchand-Brustel Y; Gugenheim J; Gual P; Tran A
    Aliment Pharmacol Ther; 2010 Dec; 32(11-12):1315-22. PubMed ID: 21050233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.
    Cerović I; Mladenović D; Ješić R; Naumović T; Branković M; Vučević D; Aleksić V; Radosavljević T
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):899-904. PubMed ID: 23426271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive liver steatosis quantification using MRI techniques combined with blood markers.
    Cesbron-Métivier E; Roullier V; Boursier J; Cavaro-Ménard C; Lebigot J; Michalak S; Calès P; Aubé C
    Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):973-82. PubMed ID: 20665947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-alcoholic fatty liver].
    Zwimpfer J
    Praxis (Bern 1994); 2000 Oct; 89(43):1757-8. PubMed ID: 11103621
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.